查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1247437

2023-2030 年胸骨闭合系统的全球市场

Global Sternal Closure Systems Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

胸骨闭合系统的全球市场规模预计到 2022 年将达到 22.9525 亿美元，到 2030 年将达到 34.4626 亿美元，在预测期间（2023-2030 年）的复合年增长率为 5.3%。

胸骨闭合系统是一种医疗器械，用于在中央胸骨切开术后闭合胸骨（胸骨），这是一种将胸骨分开以进入胸腔的外科手术。

这些系统通常由金属板、金属丝和缝合线组成，用于将分离的胸骨两半牢固地固定到位。 伤口闭合系统的目的是在癒合过程中为胸骨提供稳定性和支撑，以防止感染、伤口脱落和胸部不稳定等并发症。

市场动态

全球胸骨闭合系统市场的增长受到技术进步的推动，技术进步导致心臟和胸外科手术的发生率增加、人们越来越意识到胸骨闭合的重要性、人口老龄化以及医疗保健成本上升。增加.

心脏病负担的增加推动了市场增长

冠状动脉旁路移植术和瓣膜置换术等心臟手术的兴起增加了对胸骨闭合系统的需求

。

在世界范围内，心血管疾病 (CVD) 是导致死亡的主要原因。 心血管疾病，尤其是缺血性心脏病 (IHD) 和中风，是导致残疾的主要原因。 由于其高患病率、死亡率、发病率和治疗的经济负担，心力衰竭是一项重大的医疗保健挑战。 到 2030 年，预计将有超过 800 万美国人患有 HF。 HF 的频率随着年龄的增长而增加，从大约每 1,000 名 65 岁至 69 岁的人中有 20 人增加到每 1,000 名 85 岁及以上的人中超过 80 人。 心力衰竭最常见的原因是瓣膜性心脏病、高血压和缺血性心脏病。

此外，风湿性心脏病 (RHD) 仍然是全球 VHD 的主要原因。 另一方面，退行性瓣膜病被认为是发达国家 VHD 最常见的病因。 VHD 的患病率从 45 岁以下人群的 0.7% 增加到 75 岁以上人群的 13%。 此外，CVD 影响了世界 50% 的人口（女性）。 到 2021 年，CVD 仍然是女性发病率和死亡率的主要原因，儘管过去几十年心血管护理取得了重大进展。 城市化和生活方式的改变导致包括埃塞俄比亚在内的几个非洲国家的心血管疾病 (CVD) 发病率和患病率增加，非洲人正在经历快速的流行病学变化。

与胸骨闭合系统相关的风险阻碍了市场增长

但是，与胸骨闭合系统相关的风险是： 胸骨闭合系统会增加术后感染的风险，尤其是在切口未得到适当护理的情况下。 胸骨分离存在胸骨不稳定的风险，并可能导致疼痛、呼吸困难和其他并发症。 手术过程中可能会损伤神经，导致胸部和手臂麻木、麻木、无力。 设备故障可能导致断线和其他问题，并有需要重复手术的风险。

COVID-19 影响分析

COVID-19 大流行将对胸骨闭合系统市场产生重大负面影响。 正如 2020 年发表在《国际外科杂誌》上的一篇文章，心胸外科将不可避免地受到 COVID-19 的影响。 在英国和美国，所有选择性和非紧急手术都已推迟，资源将用于紧急和急诊心胸科服务。 此外，心臟外科医生具有可转移到 ITU 的一般技能，使他们成为重新定位的理想人选。 NHS England 发布了基于 COVID-19 大流行阶段的心胸外科管理指南。

在大流行期间，择期心胸外科服务将大大减少。 鼓励外科医生使用电话和视频会议限制面对面的预约，并延迟非紧急转诊和随访。

截至 2023 年，COVID-19 情况有所改善，所有患者都可以使用医疗设施。 此外，对心臟和胸外科手术的需求不断增加正在推动全球市场的发展

。

内容

第 1 章市场方法论和范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 患者人数增加
      • 手术次数增加
    • 抑制因素：
      • 与胸骨闭合相关的潜在风险
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • 市场上 COVID-19 的分析
    • 在 COVID-19 市场情景之前
    • 当前的 COVID-19 市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格和动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 结论

第 7 章按产品类型

  • 骨水泥
  • 关闭装置
    • 胸部闭合线
    • 用于胸骨闭合的钢板和螺钉
    • 胸口夹
    • 胸部闭合电缆

第 8 章程序

  • 正中胸骨切开术
  • Hemisiter 注意我
  • 双侧胸骨切开术

第9章材料

  • 不銹钢
  • 聚醚醚酮 (PEEK)
  • 钛
  • 其他

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 竞争场景
  • 公司股票分析
  • 产品类型基准
  • 主要发展和战略

第12章公司简介

  • Depuy Synthes（强生公司）
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Zimmer Biomet Holdings
  • KLS Martin Group
  • Acute Innovations
  • JACE Medical, LLC.
  • Stryker
  • Idear S.R.L
  • Praesidia SRL
  • Kinamed Incorporated
  • B. Braun

第13章 DataM

简介目录
Product Code: MD1456

Market Overview

The global sternal closure systems market size was valued at US$ 2,295.25 Million in 2022 and is estimated to reach US$ 3,446.26 Million by 2030, growing at a CAGR of 5.3% during the forecast period (2023-2030).

Sternal closure systems refer to medical devices used to close the sternum (breastbone) after a median sternotomy, a surgical procedure in which the sternum is split open for access to the thorax. These systems usually consist of metallic plates, wires, or sutures used to fasten the separated halves of the sternum securely. The goal of sternal closure systems is to provide stability and support to the sternum during the healing process to prevent complications such as infection, wound separation, or instability of the chest.

Market Dynamics

The global sternal closure systems market growth is driven by technological advancements increasing incidence of cardiac and thoracic surgeries, growing awareness about the importance of sternal closure, aging population, and rise in healthcare expenditure.

An increasing burden of cardiac disorders drives the market growth

The growing number of cardiac surgeries, such as coronary artery bypass grafting and valve replacements, drives the demand for sternal closure systems. Across the world, cardiovascular disease (CVD) is the leading cause of mortality. Cardiovascular diseases, principally ischemic heart disease (IHD) and stroke, are major contributors to disability. Because of the high prevalence, mortality, morbidity, and financial burden of treating heart failure (HF), it is a significant healthcare concern. It is anticipated that more than eight million Americans will have HF by 2030. From about 20 per 1,000 people aged 65 to 69 to more than 80 per 1,000 people aged 85 and older, the frequency of HF rises with age. The most frequent causes of HF are valvular heart disease, hypertension, and ischaemic heart disease.

In addition, Rheumatic heart disease (RHD) is still a leading etiologic factor in the development of VHD worldwide. In contrast, degenerative valve disease is likely the most common etiology of VHD in developed countries. The prevalence of VHD increases from 0.7 % in people<45 years to 13 % in people over 75 years. Moreover, CVD affects 50% of the world's population (women). Despite significant progress in cardiovascular care over the past several decades, in 2021, CVD remains the major cause of morbidity and mortality for women. Urbanization and lifestyle modifications are contributing to a rise in the incidence and prevalence of cardiovascular diseases (CVDs) across several African nations, including Ethiopia, as Africans experience a rapid epidemiological transformation.

The risk associated with sternal closure systems will hamper the growth of the market

However, the risks associated with sternal closure systems. Sternal closure systems can increase the risk of postoperative infections, particularly if the incision is not properly cared for. There is a risk of sternal instability, which can cause the chest bones to separate and lead to pain, difficulty breathing, and other complications. There is a risk of nerve damage during the procedure, which can result in numbness, tingling, or weakness in the chest or arms. There is a risk of the device malfunction, which can lead to broken wires or other issues that require revision surgery. There is a risk of allergic reactions to the materials used in the sternal closure system, such as metals or adhesives.

COVID-19 Impact Analysis

The COVID-19 pandemic has profound adverse effects on the sternal closure systems market. As per the article published in the International Journal of Surgery in 2020, cardiothoracic practice will be inevitably affected by COVID-19. All elective and non-urgent procedures have been postponed in the UK and the US, with resources being redirected to the emergency and urgent cardiothoracic service. Furthermore, cardiothoracic surgeons possess generic skills which are mostly transferable to ITU, making them prime candidates for redeployment. NHS England has issued guidance on managing cardiothoracic procedures based on the phase of the COVID-19 pandemic.

The elective cardiothoracic surgery service will be greatly reduced throughout the pandemic. Surgeons are encouraged to use telephone and video conferencing to limit face-to-face appointments and to delay non-urgent referrals and follow-ups. Cardiothoracic surgeons can greatly support the ITU service, and attempts should be made to make senior staff available for redeployment.

As of 2023, the COVID-19 situation is recovering, and all patients can access healthcare facilities. In addition, increasing demand for cardiac and thoracic surgeries drives the market worldwide.

Segment Analysis

The closure devices segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The closure devices segment accounts for the highest market share. Sternal closure devices are used in cardiac surgery to securely close the sternum after a median sternotomy (an incision made down the center of the breastbone). The devices are designed to reduce the time required for sternal healing, minimize wound complications, and reduce patient discomfort compared to traditional wire cerclage methods. There has been increasing demand for sternal closure devices in recent years due to their benefits and technological advancements. Cardiac surgery procedures are becoming more prevalent due to an aging population and advancements in medical technology, leading to a growing demand for reliable and efficient sternal closure methods. Additionally, the benefits of faster recovery time and reduced patient discomfort associated with sternal closure devices have increased demand among patients and healthcare providers.

In addition, Medicon offers a titanium sternal closure system that allows stable internal fixation of the sternum after sternotomy or sternal fracture. Different titanium plates are available to suit the anatomical structures and individual clinical requirements. Also, Arthrex, Inc. offers A 100% nonmetallic, suture-based alternative to the conventional use of metal wires to bind the sternum after heart surgery, the FiberTape sternal closure system. Strong, repeatable compression from the FiberTape sternal closure implant, which is placed similarly to metal wires, aids in sternal approximation and stabilization.

Geographical Analysis

North America region holds the largest market share of the global sternal closure systems market

North America dominates the market for sternal closure systems and is expected to show a similar trend over the forecast period. Technological advancements, the rising prevalence of cardiac disease, and product launches by market players in the North American region drive the market.

As per the article published in the Journal of Thoracic Disease in 2022, In the U.S., thoracic surgeons can complete their training through various extremely competitive programs and are prepared to manage patients with chest problems during surgery and in the immediate aftermath. An average of 135 procedures are carried out by thoracic surgeons each year to treat conditions affecting the lungs, trachea, esophagus, chest wall, mediastinum, and diaphragm. The most frequent surgeries, usually done to treat lung cancer, are thoracoscopic surgeries with video assistance. With over 200,000 new cases anticipated this year, lung cancer is the deadliest and the second most common cancer in the U.S.

Additionally, the University of Michigan Medicine performs about 2,000 adult cardiac surgery procedures yearly using improving and cutting-edge therapies for heart and aortic illnesses.

Competitive Landscape

The sternal closure systems market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Depuy Synthes (Johnson & Johnson), Zimmer Biomet Holdings, KLS Martin Group, Acute Innovations, JACE Medical, LLC., Stryker, Idear S.R.L, Praesidia SRL, Kinamed Incorporated, and B. Braun, among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the sternal closure systems market globally.

For instance,

  • In December 2020, Zimmer Biomet Holdings, Inc., acquired the Stryker Corporation, a Vance Street Capital Portfolio Company, for $150 million in cash at closing and $100 million in cash payable in 2021. Zimmer Biomet has acquired Stryker and its complete product portfolio of sternal closure devices - including cable systems, sternal sutures, and rigid fixation - along with a range of single-use complimentary temporary pacing wire and surgical punch products.

Zimmer Biomet Holdings

Overview:

Zimmer Biomet is a medical device company founded in 1927 and headquartered in the U.S. Their innovations enable the treatment of disorders of, or injuries to, joints, bones, and supporting soft tissues. Together with healthcare professionals, a company helps millions of people to live better lives.

Product Portfolio:

SternaLock XP Rigid Fixation System: The SternaLock XP Sternal Closure System is implied for stabilizing and fixing fractures of the anterior chest wall for sternal reconstructive procedures for patients with normal and poor bone.

The global sternal closure systems market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The rise in the patient population
      • 4.1.1.2. The increase in the number of surgical procedures
    • 4.1.2. Restraints:
      • 4.1.2.1. Potential Risks Associated with Sternal Closure
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Bone cement*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 7.3. Closure devices
    • 7.3.1. Sternal closure wires
    • 7.3.2. Sternal closure plates and screws
    • 7.3.3. Sternal closure clips
    • 7.3.4. Sternal closure cables

8. By Procedure

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 8.1.2. Market Attractiveness Index, By Procedure
  • 8.2. Median Sternotomy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Hemisternotomy
  • 8.4. Bilateral Thoracosternotomy

9. By Material

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 9.1.2. Market Attractiveness Index, By Material
  • 9.2. Stainless Steel*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Polyether Ether Ketone (PEEK)
  • 9.4. Titanium
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Material

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Company Share Analysis
  • 11.3. Product Type Benchmarking
  • 11.4. Key Developments and Strategies

12. Company Profiles

  • 12.1. Depuy Synthes (Johnson & Johnson)*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Zimmer Biomet Holdings
  • 12.3. KLS Martin Group
  • 12.4. Acute Innovations
  • 12.5. JACE Medical, LLC.
  • 12.6. Stryker
  • 12.7. Idear S.R.L
  • 12.8. Praesidia SRL
  • 12.9. Kinamed Incorporated
  • 12.10. B. Braun

LIST NOT EXHAUSTIVE

13. Global Sternal Closure Systems Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us